Recently, Incorvaia et al. found that the expression of several miRNAs derived from peripheral lymphocytes of RCC patients was associated with the soluble levels of PD-1 and PD-L1 in plasma. This evidence concerns the gene PDCD1 and renal cell carcinoma.